{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:05:52Z","timestamp":1773198352897,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11095-019-2568-9","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T11:19:08Z","timestamp":1547205548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Population Dynamic Energy Budget-Based Tumor Growth Inhibition Model for Etoposide Effects on Wistar Rats"],"prefix":"10.1007","volume":"36","author":[{"given":"E. M.","family":"Tosca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Pigatto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Dalla Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-4676","authenticated-orcid":false,"given":"P.","family":"Magni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"issue":"8","key":"2568_CR1","first-page":"785","volume":"12","author":"L Carrara","year":"2017","unstructured":"Carrara L, Lavezzi SM, Borella E, De Nicolao G, Magni P, Poggesi I. Current mathematical models for cancer drug discovery. Expert Opin Drug Discovery. 2017;12(8):785\u201399.","journal-title":"Expert Opin Drug Discovery"},{"key":"2568_CR2","doi-asserted-by":"crossref","unstructured":"Bonate PL. Modeling tumor growth in oncology. In: Pharmacokinetics in drug development: Springer; 2011. p. 1\u201319.","DOI":"10.1007\/978-1-4419-7937-7_1"},{"issue":"5","key":"2568_CR3","first-page":"1","volume":"3","author":"B Ribba","year":"2014","unstructured":"Ribba B, Holford NH, Magni P, Troc\u00f3niz I, Gueorguieva I, Girard P, et al. A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis. CPT: Pharmacometrics & Systems Pharmacology. 2014;3(5):1\u201310.","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"8","key":"2568_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003800","volume":"10","author":"S Benzekry","year":"2014","unstructured":"Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JM, Hlatky L, et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014;10(8):e1003800.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"2568_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.drudis.2008.01.003","volume":"13","author":"I Rajman","year":"2008","unstructured":"Rajman I. PK\/PD modelling and simulations: utility in drug development. Drug Discov Today. 2008;13(7):341\u20136.","journal-title":"Drug Discov Today"},{"issue":"3","key":"2568_CR6","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1016\/j.ddtec.2012.07.004","volume":"10","author":"M Simeoni","year":"2013","unstructured":"Simeoni M, Nicolao GD, Magni P, Rocchetti M, Poggesi I. Modeling of human tumor xenografts and dose rationale in oncology. Drug Discov Today Technol. 2013;10(3):e365\u201372.","journal-title":"Drug Discov Today Technol"},{"issue":"9","key":"2568_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1517\/17425255.2012.693480","volume":"8","author":"A Bernard","year":"2012","unstructured":"Bernard A, Kimko H, Mital D, Poggesi I. Mathematical modeling of tumor growth and tumor growth inhibition in oncology drug development. Expert Opin Drug Metab Toxicol. 2012;8(9):1057\u201369.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"2568_CR8","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","volume":"64","author":"M Simeoni","year":"2004","unstructured":"Simeoni M, Magni P, Cammia C, De Nicolao G, Croci V, Pesenti E, et al. Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents. Cancer Res. 2004;64(3):1094\u2013101.","journal-title":"Cancer Res"},{"issue":"3","key":"2568_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1742-7843.2005.pto960325.x","volume":"96","author":"M Rocchetti","year":"2005","unstructured":"Rocchetti M, Poggesi I, Germani M, Fiorentini F, Pellizzoni C, Zugnoni P, et al. A pharmacokinetic-pharmacodynamic model for predicting tumour growth inhibition in mice: a useful tool in oncology drug development. Basic Clin Pharmacol Toxicol. 2005;96(3):265\u20138.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2568_CR10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ejca.2006.10.015","volume":"43","author":"S Garattini","year":"2007","unstructured":"Garattini S. Pharmacokinetics in cancer chemotherapy. Eur J Cancer. 2007;43(2):271\u201382.","journal-title":"Eur J Cancer"},{"issue":"19","key":"2568_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tr\u00e9dan","year":"2007","unstructured":"Tr\u00e9dan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19):1441\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"2568_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1158\/0008-5472.CAN-05-3077","volume":"66","author":"R Grantab","year":"2006","unstructured":"Grantab R, Sivananthan S, Tannock IF. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res. 2006;66(2):1033\u20139.","journal-title":"Cancer Res"},{"key":"2568_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jtbi.2018.04.012","volume":"450","author":"N Terranova","year":"2018","unstructured":"Terranova N, Tosca EM, Pesenti E, Rocchetti M, Magni P. Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: a dynamic energy budget (DEB) approach. J Theor Biol. 2018;450:1\u201314.","journal-title":"J Theor Biol"},{"issue":"6","key":"2568_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1021336321551","volume":"3","author":"I Leeuwen Van","year":"2002","unstructured":"Van Leeuwen I, Kelpin F, Kooijman S. A mathematical model that accounts for the effects of caloric restriction on body weight and longevity. Biogerontology. 2002;3(6):373\u201381.","journal-title":"Biogerontology"},{"issue":"12","key":"2568_CR15","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/sj.bjc.6601394","volume":"89","author":"I Leeuwen Van","year":"2003","unstructured":"Van Leeuwen I, Zonneveld C, Kooijman S. The embedded tumour: host physiology is important for the evaluation of tumour growth. Br J Cancer. 2003;89(12):2254\u201363.","journal-title":"Br J Cancer"},{"key":"2568_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejps.2016.10.038","volume":"97","author":"MC Pigatto","year":"2017","unstructured":"Pigatto MC, Roman RM, Carrara L, Buffon A, Magni P, Dalla Costa T. Pharmacokinetic\/ pharmacodynamic modeling of etoposide tumor growth inhibitory effect in Walker-56 tumor-bearing rat model using free intratumoral drug concentrations. Eur J Pharm Sci. 2017;97:70\u20138.","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"2568_CR17","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1200\/JCO.1995.13.11.2835","volume":"13","author":"S Kaul","year":"1995","unstructured":"Kaul S, Igwemezie LN, Stewart DJ, Fields SZ, Kosty M, Levithan N, et al. Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors. J Clin Oncol. 1995;13(11):2835\u201341.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2568_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1046\/j.0306-5251.2001.01468.x","volume":"52","author":"G Toffoli","year":"2001","unstructured":"Toffoli G, Corona G, Sorio R, Robieux I, Basso B, Colussi AM, et al. Population pharmacokinetics and pharmacodynamics of oral etoposide. Br J Clin Pharmacol. 2001;52(5):511\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"2568_CR19","unstructured":"Brazil. Lei 11.794\/2008: Procedimentos para Uso Cientifico de Animais; 2008. CXLV, 196, 1-2. Diario Oficial da Uniao, Secao 1 de 9 de outubro de 2008."},{"key":"2568_CR20","unstructured":"Brazil. Ministerio de Ciencia, Tecnologia e Inovacao Conselho Nacional de Controle de Experimentacao Animal; 2013. -CONCEA. Diretriz Brasileira para o cuidado e a utilizacao de animais para fins cientificos e didaticos- DBCA. Brasilia - DF."},{"key":"2568_CR21","unstructured":"NCI. 2012 Frederick ACUC Guidelines Involving Experimental Neoplasia Proposals in Mice and Rats; \n                    https:\/\/es.scribd.com\/document\/139069470\/ACUC14\n                    \n                   (accessed 0.10.3.14)."},{"issue":"7","key":"2568_CR22","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s11095-016-1906-4","volume":"33","author":"MC Pigatto","year":"2016","unstructured":"Pigatto MC, de Araujo BV, Torres BGS, Schmidt S, Magni P, Dalla Costa T. Population pharmacokinetic modeling of etoposide free concentrations in solid tumor. Pharm Res. 2016;33(7):1657\u201370.","journal-title":"Pharm Res"},{"key":"2568_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fphar.2014.00174","volume":"5","author":"T Tuntland","year":"2014","unstructured":"Tuntland T, Ethell B, Kosake T, Blasco F, Zang RX, Jain M, et al. Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Front Pharmacol. 2014;5:174.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2568_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/bdd.539","volume":"28","author":"X Li","year":"2007","unstructured":"Li X, Yun JK, Choi JS. Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007;28(3):151\u20136.","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"2568_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/bdd.754","volume":"32","author":"CK Lee","year":"2011","unstructured":"Lee CK, Ki SH, Choi JS. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharm Drug Dispos. 2011;32(4):245\u201351.","journal-title":"Biopharm Drug Dispos"},{"key":"2568_CR26","unstructured":"Kooijman SALM. Dynamic energy budgets in biological systems. Cambridge university press; 1993."},{"key":"2568_CR27","doi-asserted-by":"crossref","unstructured":"Kooijman SALM. Dynamic energy and mass budgets in biological systems. Cambridge university press 2000.","DOI":"10.1017\/CBO9780511565403"},{"issue":"1407","key":"2568_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1098\/rstb.2000.0771","volume":"356","author":"SALM Kooijman","year":"2001","unstructured":"Kooijman SALM. Quantitative aspects of metabolic organization: a discussion of concepts. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 2001;356(1407):331\u201349.","journal-title":"Philosophical Transactions of the Royal Society of London B: Biological Sciences"},{"key":"2568_CR29","unstructured":"Lixoft. Monolix version 2016 R; \n                    http:\/\/lixoft.com\/products\/monolix\/\n                    \n                  ."},{"key":"2568_CR30","doi-asserted-by":"crossref","unstructured":"Lavielle M. Mixed effects models for the population approach: models, tasks, methods and tools. CRC press; 2014.","DOI":"10.1201\/b17203"},{"issue":"21","key":"2568_CR31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/jnci\/djn351","volume":"100","author":"MG Hollingshead","year":"2008","unstructured":"Hollingshead MG. Antitumor efficacy testing in rodents. JNCI: Journal of the National Cancer Institute. 2008;100(21):1500\u201310.","journal-title":"JNCI: Journal of the National Cancer Institute"},{"issue":"3","key":"2568_CR32","first-page":"878","volume":"8","author":"IF Tannock","year":"2002","unstructured":"Tannock IF, Lee CM, Tunggal JK, Cowan DS, Egorin MJ. Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clin Cancer Res. 2002;8(3):878\u201384.","journal-title":"Clin Cancer Res"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2568-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:17:18Z","timestamp":1578683838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2568-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2568-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}